RxDoctor Payments Data

Erin Hartwick

Adult Health · Cape Coral, FLNPI 1396293486

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,726 of the $4,103 with a category attached, or 66.4%. 20 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 33.6% of the total. Reporting peaked in 2022 at $2,226 and has fallen 79.5% since, to $456 in 2025.

$4,103in general payments, 2019–2025

Across 133 payments — averaging $30.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Respicardia, Inc.$1K
  • AstraZeneca$887
  • GSK$592
  • Boehringer Ingelheim$269
  • Teva Pharmaceuticals USA, Inc.$196
  • Paratek Pharmaceuticals, Inc.$135
  • plus $646 from 14 others

What the payments were for

  • Travel & lodging$1,37734%
  • Food & beverage$2,72666%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,103 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida →

Other adult health in Cape Coral

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →